Lemaitre Vascular LMAT
NASDAQ LMAT
$78.74 -0.73 (-0.92%)
As of: Sep 10, 2026 · 3:59 PM EDT

Lemaitre Vascular (LMAT) Other financing activities (2014 - 2026)

Lemaitre Vascular's (LMAT) quarterly Other financing activities came in at $776000.0 in Q2 2026, down 55.91% year-over-year from $1.8 million in Q2 2025, and down 73.71% quarter-over-quarter from $3.0 million in Q1 2026.

Analysis

Lemaitre Vascular (LMAT) Other financing activities (2014 - 2026) Analysis & Trends

Lemaitre Vascular (LMAT) has reported Other financing activities for 6 consecutive years, with $776000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other financing activities fell 55.91% year-over-year to $776000.0 in Q2 2026; TTM through Jun 2026 was $7.5 million, a 55.94% increase from a year earlier, with the FY2025 full-year figure at $6.8 million, up 5.95% from the prior year.
  • Other financing activities was $776000.0 for Q2 2026 at Lemaitre Vascular, down from $3.0 million in the prior quarter.
  • Over five years, Other financing activities peaked at $4.0 million in Q1 2024 and troughed at $449000.0 in Q3 2024.
  • A 5-year average of $1.7 million and a median of $1.4 million in 2023 frame the typical range for Other financing activities.
  • Across the five-year window, Other financing activities tumbled 79.87% in 2024 and jumped 253.01% in 2025, its largest moves.
  • Over 5 years, Other financing activities stood at $508000.0 in 2022, then jumped by 121.85% to $1.1 million in 2023, then gained by 13.13% to $1.3 million in 2024, then soared by 69.88% to $2.2 million in 2025, then tumbled by 64.17% to $776000.0 in 2026.
  • The last three Other financing activities figures came in at $776000.0 (Q2 2026), $3.0 million (Q1 2026), and $2.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn
10 Lemaitre Vascular 1.80 Bn 1.43 Bn 50.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 776,000.00
Mar 31, 2026 2.95 Mn
Dec 31, 2025 2.17 Mn
Sep 30, 2025 1.59 Mn
Jun 30, 2025 1.76 Mn
Mar 31, 2025 1.31 Mn
Dec 31, 2024 1.28 Mn
Sep 30, 2024 449,000.00
Jun 30, 2024 730,000.00
Mar 31, 2024 3.99 Mn
Dec 31, 2023 1.13 Mn
Jun 30, 2023 3.63 Mn
Mar 31, 2023 1.45 Mn
Mar 31, 2022 508,000.00
Dec 31, 2014 197,000.00
Mar 31, 2014 28,000.00